4//SEC Filing
Nazak Michael Adrian 4
Accession 0001104659-20-003445
CIK 0001614067other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:02 PM ET
Size
5.1 KB
Accession
0001104659-20-003445
Insider Transaction Report
Form 4
Nazak Michael Adrian
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Options
2020-01-02+20,000→ 60,000 totalExercise: $4.45Exp: 2030-01-02→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest in equal installments over 48 months, beginning on January 2, 2020.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001799731
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:02 PM ET
- Size
- 5.1 KB